Gynecological Cancer

Choriocarcinoma, a rare and once fatal solid tumour that develops from trophoblasts during pregnancy, is today one of the most curable of cancers, with a 100% survival rate among women with low-risk disease and 98% survival rate in high-risk disease.

Ovarian cancer is a significant health concern, being globally the eighth most common cancer in women, accounting for an estimated 3.7% of cases and 4.7% of cancer deaths in 2020 (Webb et al 2024). Until the early 2000s, age-standardized incidence was highest in Northern Europe and North America, but this trend has changed; incidence is now declining in these regions and increasing in parts of Eastern Europe and Asia.

The origins and development of a multidisciplinary research field aimed to supporting and helping patients to have children after or during cancer treatment.

Human papilloma virus is the causative factor of >90% of cervical cancer and few other tumour types. In this narrative review, the role of European research in identifying HPV function in cancer development, screening and prevention is illustrated through the voices of 3 key players, that actively contributed to the launch of the 2018 WHO campaign to eliminate cervical cancer.